New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

Today's Free Fly Stories
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | all day >>
10:32 EDTFRMMustang Capital issues open letter to Furmanite shareholders
Subscribe for More Information
10:31 EDTANGI, ONDKAngie's List announces partnership with On Deck Capital
Angie's List (ANGI) announced plans to team with On Deck Capital (ONDK) to offer financing to its service providers. As part of this agreement, service providers on Angie’s List will have access to OnDeck’s loans for up to $250,000. Qualifying service providers can use their loans to invest in their business’ growth, manage cash flow or finance their Angie’s List subscriptions.
10:30 EDTEnergy Action: NYMEX crude has rallied to four-month highs
Subscribe for More Information
10:29 EDTPNK, PSEC, TWCOptions with increasing implied volatility: PNK PSEC TWC
Subscribe for More Information
10:29 EDTGWPHFly Watch: Added data on marijuana-derived epilepsy drug coming this week
GW Pharmaceuticals (GWPH) is expected to report additional results of a Phase III trial of its Epidiolex drug at the American Academy of Neurology's annual meeting on April 22. BACKGROUND: Made from cannabidiol, a non-psychoactive compound in marijuana, Epidolex is being tested as a treatment for certain forms of childhood epilepsy. Some data from the study was released on April 13 by the American Academy of Neurology, or AAN. That data was from physician-led FDA authorized Epidiolex "expanded access" programs for children and young adults with treatment-resistant epilepsy that have exhausted available treatment options, GW Pharmaceuticals stated. ANALYST TAKE: The risk/reward ratio for GW's stock is positive heading into the release of additional data on April 22, Leerink analyst Paul Matteis wrote in a note to investors earlier today. Investors are likely focused on three data points within the additional information, namely response rate data, whether the media overall seizure reduction differs from an October trial report when it was 36%, and the degree to which seizure reductions are sustained beyond 12 weeks. Given the study's lack of a placebo arm, investors may be most focused on the seizure reductions, as this is seen as a good indication as to whether controlled Phase III studies will be successful, wrote Matteis. Experts say that Epidiolex may be used to treat additional types of epliepsy if the Phase III data is positive, given its efficacy in difficult to treat patients and its superior safety profile compared with other epilepsy treatments, the analyst stated. The data already released from the latest study showed a "much greater" magnitude of overall seizure reduction than in the October update and a "consistent, robust effect" in larger samples of pediatric epilepsy patients, wrote Matteis, who raised his estimates of Epidiolex peak market penetrations and raised his price target on the stock to $120 from $102 while keeping an Outperform rating on the shares. PRICE ACTION: Shares of GW Pharmaceuticals are down $2, or 1.75%, to %112 per share in early trading. The stock has gained about 65% over the last six months.
10:22 EDTHZOMarineMax upgraded to Buy from Neutral at Northcoast
Subscribe for More Information
10:16 EDT$NYENYSE market internals summary
Subscribe for More Information
10:16 EDT$NSDNASDAQ market internals summary
Volume is light for this time of day. Breadth is bullish across the board. Advancing Issues: 1683 / Declining Issues: 742 -- for a ratio of 2.3 to 1. Advancing Volume: 160,156,000 / Declining Volume: 70,343,000 -- for a ratio of 2.3 to 1. New 52-Week Highs: 28 / New 52-Week Lows: 9.
10:16 EDTRANDRand Capital invests $500K in medical device manufacturer
Subscribe for More Information
10:14 EDTRCLRoyal Caribbean says committed to 'double double' goal
Subscribe for More Information
10:11 EDTBPT, WETF, NFLX, BMRN, SNDK, STX, TSM, MAT, FASTOptions with decreasing implied volatility
Options with decreasing implied volatility: BPT WETF NFLX BMRN SNDK STX TSM MAT FAST INTC
10:10 EDTBIOCLiquid biopsy among cancer advances discussed at AACR meeting, Forbes says
Subscribe for More Information
10:07 EDTLPILaredo Petroleum downgraded to Market Perform from Outperform at Raymond James
Subscribe for More Information
10:05 EDTA Slight April Bounce for U.S. Sentiment:
A Slight April Bounce for U.S. Sentiment: The downdraft for U.S. producer sentiment may have abated somewhat in April, given improvement in the component data for the Empire State and Philly Fed reports despite unimpressive headlines. On an ISM-adjusted basis, the Empire survey held steady in April while the Philly Fed posted a welcome bounce. Analysts expect ISM-adjusted average of all the major surveys to improve slightly to 51 in April, after a lean 50 average in March, though higher 52 averages in January and February and a 55 average as recently as November.
10:03 EDTVVUS, TNET, KEY, ICON, BMS, VIMC, FNV, CHKP, HAS, OILHigh option volume stocks
Subscribe for More Information
10:03 EDTNYMXNymox announces positive trial results for NX-1207 Phase 2 prostate cancer study
Subscribe for More Information
10:02 EDTPRAA, GNWPRA Group names Deborah Cassidy as Chief Information Officer
PRA Group (PRAA) announced the appointment of Deborah G. Cassidy as a new member of PRA Group's executive management team. Cassidy will serve as chief information officer for the company. Most recently, Cassidy was senior vice president and business chief information officer for Genworth Financial (GNW).
10:01 EDTNOCNorthrop Grumman, Caltech establish space solar power initiative
Subscribe for More Information
10:00 EDTCMTLComtech received $1.3M order for satellite modems
Subscribe for More Information
10:00 EDTWUBA, ADRO, BABA, BIDU, ELY, CLLS, CYOU, CMCM, CTRP, DYN, FMC, FSB, GVA, HSY, JD, JMEI, MUX, NGS, NRZ, PAH, QIHU, QUNR, SINA, SWHC, SOHU, SEDG, SPLK, DATA, TMH, TOUR, VIPS, VSTO, WB, YY, YOKU, ZPINOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: 58.com (WUBA) initiated with a Hold at Summit Research... Aduro Biotech (ADRO) initiated with a Buy at Roth Capital... Alibaba (BABA) initiated with a Buy at Summit Research... Baidu (BIDU) initiated with a Buy at Summit Research... Callaway Golf (ELY) initiated with a Buy at Jefferies... Cellectis (CLLS) initiated with a Buy at Jefferies... Changyou.com (CYOU) initiated with a Buy at Summit Research... Cheetah Mobile (CMCM) initiated with a Buy at Summit Research... Ctrip.com (CTRP) initiated with a Hold at Summit Research... Dynegy (DYN) initiated with an Overweight at Morgan Stanley... FMC Corporation (FMC) initiated with a Neutral at Monness Crespi... Franklin Financial Network (FSB) initiated with a Buy at BofA/Merrill... Granite Construction (GVA) initiated with an Outperform at Cowen... Hershey (HSY) initiated with a Reduce at Nomura... JD.com (JD) initiated with a Hold at Summit Research... Jumei (JMEI) initiated with a Buy at Summit Research... McEwen Mining (MUX) initiated with a Buy at H.C. Wainwright... Natural Gas Services (NGS) initiated with a Neutral at Sidoti... New Residential (NRZ) initiated with a Buy at BofA/Merrill... Platform Specialty Products (PAH) initiated with an Outperform at Credit Suisse... Qihoo 360 (QIHU) initiated with a Buy at Summit Research... Qunar (QUNR) initiated with a Buy at Summit Research... SINA (SINA) initiated with a Hold at Summit Research... Smith & Wesson (SWHC) initiated with a Sector Perform at RBC Capital... Sohu.com (SOHU) initiated with a Hold at Summit Research... SolarEdge (SEDG) initiated with a Buy at Deutsche Bank... Splunk (SPLK) initiated with a Buy at Citigroup... Tableau (DATA) initiated with a Neutral at Citigroup... Team Health (TMH) initiated with an Outperform at Leerink... Tuniu (TOUR) initiated with a Buy at Summit Research... Vipshop (VIPS) initiated with a Buy at Summit Research... Vista Outdoor (VSTO) initiated with an Outperform at RBC Capital... Weibo (WB) initiated with a Buy at Summit Research... YY Inc. (YY) initiated with a Buy at Summit Research... Youku Tudou (YOKU) initiated with a Hold at Summit Research... Zhaopin (ZPIN) initiated with a Hold at Summit Research.
<< 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | all day >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use